Indefinite Delivery Contract 75D30126D21004
Award Date 6/1/26
Last Date to Order 5/31/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery, Multiple Award contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on June 1, 2025, establishes a procurement vehicle for adult COVID-19 vaccines with a ceiling value of $786.47 million and a performance period extending through May 31, 2026. The contract was awarded to Pfizer Inc., a large pharmaceutical manufacturer with extensive experience delivering critical medical products to federal healthcare agencies. As a non-set-aside...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Sanofi Vaccines US Inc. on June 1, 2026, with a ceiling of $15,682,800 to procure FDA-approved COVID-19 vaccines for adults aged 19 and older through May 31, 2027. The solicitation, posted March 4, 2026 with proposals due March 17, 2026, sought vaccines to support the Section 317 immunization program, which distributes vaccines to state and local health departments across all fifty states,...
- Pfizer Inc. has been awarded a multiple-award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) for the procurement of COVID-19 adult vaccines. This contract, valued at $347.2 million, was executed on June 1, 2024, with an ultimate completion date of September 30, 2025. The contract does not utilize small business set-aside designations, reflecting Pfizer's status as an established pharmaceutical manufacturer capable of meeting extensive government medical...
- The Centers for Disease Control and Prevention (CDC) awarded a multiple-award indefinite-delivery contract to Pfizer Inc. on June 1, 2026, with a ceiling of $735,720,598 for pediatric COVID-19 vaccines under the Vaccine for Children (VFC) program. The contract has no set-aside designation and a completion date of May 31, 2027. Place of performance centers in Chamblee, Georgia, with vaccine delivery to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky...
- The Centers for Disease Control and Prevention, on behalf of its Office of Acquisition Services, awarded an indefinite-delivery, multiple-award contract to Moderna US, Inc. with a ceiling value of $29,183,000 and an award date of June 1, 2026. The contract runs through May 31, 2027. The solicitation, posted March 4, 2026 with proposals due March 17, 2026, sought FDA-approved COVID-19 vaccines for adults aged 19 and older to support the Section 317 immunization program, which distributes vaccines...
- Pfizer Inc. was awarded a multiple-award Indefinite Delivery Contract valued at $102.6 million by the Centers for Disease Control and Prevention (CDC) Pittsburgh on June 25, 2021, to supply 13 standard adult vaccines through June 30, 2022. The contract procures hepatitis A, hepatitis B, hepatitis A/B combination, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, tetanus/diphtheria/acellular pertussis, measles/mumps/rubella, meningococcal conjugate, human papillomavirus,...
- Pfizer Inc. was awarded a multiple-award indefinite delivery contract valued at $3.3 million by the Centers for Disease Control and Prevention (CDC) Pittsburgh to supply various adult vaccines for the period of July 1, 2024 through June 30, 2025. The contract operates as an indefinite-delivery, indefinite-quantity vehicle with no small business set-aside, enabling the CDC's National Center for Immunization and Respiratory Diseases to procure vaccines through the CDC's Vaccine Tracking System...
- The Centers for Disease Control and Prevention (CDC) has awarded Pfizer Inc. an Indefinite Delivery Contract (IDC) for the supply of various adult vaccines to support immunization programs under Section 317(j) of the Public Health Service Act. The $103,060,230.33 contract, which runs from July 1, 2023 to June 30, 2024, covers a range of vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles-mumps-rubella, meningococcal...
- The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines. As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles (IDVs),...
- Pfizer Inc. was awarded a multiple-award Indefinite Delivery/Indefinite Quantity contract valued at $2.21 billion by the Centers for Disease Control and Prevention (CDC) to supply pediatric vaccines for the Vaccines for Children (VFC) program. The contract period runs from April 1, 2025, through March 31, 2026, with no set-aside designation. Under this solicitation, Pfizer will manufacture and deliver standard commercial pediatric vaccines meeting FDA licensing requirements and maintaining a...